Aoyama Yasutaka, Yamamura Ryousuke, Shima Etsuko, Nakamae Hirohisa, Makita Kaori, Hasegawa Taro, Sakamoto Chikahiko, Terada Yoshiki, Kho Genzyu, Ohta Kensuke, Yamane Takahisa, Takubo Takayuki, Hino Masayuki
Graduate School of Medicine, Osaka City University.
Rinsho Ketsueki. 2003 Jul;44(7):451-5.
Visceral disseminated varicella-zoster virus (VZV) infection occurred with acute graft-versus-host disease in a 33-year-old Japanese male with non-Hodgkin lymphoma who had undergone allogeneic stem cell transplantation from an HLA-identical sibling after reduced intensity conditioning chemotherapy. Although ganciclovir and acyclovir treatment was effective temporarily, the number of VZV-DNA copies in the blood remained at a high level, and the hepatitis was prolonged. The patient was treated with foscarnet, which led to improvement of the VZV viremia and the hepatic dysfunction. Foscarnet therapy should be considered for acyclovir-resistant VZV infection in the setting of allogeneic hematopoietic stem cell transplantation.
一名33岁的日本男性非霍奇金淋巴瘤患者在接受强度降低的预处理化疗后,接受了来自 HLA 相同同胞的异基因干细胞移植,发生了伴有急性移植物抗宿主病的内脏播散性水痘带状疱疹病毒(VZV)感染。尽管更昔洛韦和阿昔洛韦治疗暂时有效,但血液中VZV-DNA拷贝数仍维持在高水平,肝炎病程延长。该患者接受了膦甲酸钠治疗,这使得VZV病毒血症和肝功能障碍得到改善。对于异基因造血干细胞移植背景下的阿昔洛韦耐药VZV感染,应考虑膦甲酸钠治疗。